Irene Ghobrial

Lavine Family Chair for Preventative Cancer Therapies · Mass General Brigham

Credentials: · · · ·

History

Mass General Brigham
Present
Center for Early Detection and Interception of Blood Cancers · Mass General Brigham
Present

Precision Interception for MGUS/SMM
National Cancer Institute · P01
Contact PI · $2.5M · Dana-Farber Cancer Inst
2026–2031
Myeloma Multidimensional Precancer Atlas
National Cancer Institute · U01
Contact PI · $5.6M · Dana-Farber Cancer Inst
2024–2029
Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation
National Cancer Institute · R35
Contact PI · $5.1M · Dana-Farber Cancer Inst
2022–2029
Molecular Prediction of Myeloma in African Americans
National Cancer Institute · U01
Contact PI · $2.6M · Dana-Farber Cancer Inst
2022–2027

CAR- PRISM (PRecision Intervention Smoldering Myeloma)
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2023–2040
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Principal investigator · Recruiting · Phase 2
Irene Ghobrial, MD
2022–2030
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Principal investigator · Enrolling by invitation
Dana-Farber Cancer Institute
2018–2033
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2017–2026